Seniprutug

N/A

Report date: 2025/05/15 11:45:51

Base Information

Drug NameSeniprutug
Drug Alias NameBCD-180
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-T cell receptor beta variable 9
TargetsT cell receptor beta variable 9
Therapy Area/IndicationsAxial Spondyloarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian FederationBelarus
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesBIOCAD JSC
China Registration ClassN/A

Develop Information

Active CompaniesBIOCAD JSC
Inactive CompaniesN/A
Active IndicationsAxial Spondyloarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A